PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

A09276 Establishes the "safeguarding reproductive care act" under which a stockpile of mifepristone and misoprostol is maintained and managed to ensure continued access to reproductive care medications within the state.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 90%

Creates and maintains a state stockpile of mifepristone and misoprostol, makes it available to providers at no cost to patients, and allows dispensing via telehealth or electronic prescription, increasing access to medication abortion drugs within the state.

The commissioner shall establish and maintain a stockpile or stockpiles of mifepristone and misoprostol in such quantities as necessary to ensure continued access to such drugs within the state.

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

Expands abortion access model confidence 80%

Authorizes and regulates the establishment, maintenance, and dispensing from a state reproductive care drugs stockpile under the department of health, including procedures for inventory, security, restocking, and telehealth/electronic prescriptions, facilitating provider access to medication for use

The establishment, maintenance, and operation of the reproductive care drugs stockpile pursuant to section twenty-five hundred ninety-nine-bb-two of the public health law, and the dispensing of drugs from such stockpile shall be under the direction of the department of health or by providers specified by the department of health.

✓ Quote verified word for word in the bill text

Abortion funding insuranceAI label

Expands abortion access model confidence 85%

Requires the state to maintain a stockpile of mifepristone and misoprostol and provide it at no cost to patients through specified providers, effectively using public resources to cover the cost of medication abortion drugs.

Any provider of reproductive health services receiving mifepristone or misoprostol from the state stockpile shall dispense such drugs at no cost to patients.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2026-01-07: referred to health
Filed
2025-11-21
Committee
Health
Sponsor
Linda Rosenthal D + 2 cosponsors (2 D)

Why the model tagged it this way: The bill creates a state-managed stockpile of mifepristone and misoprostol to ensure continued access, provides it at no cost to patients, authorizes dispensing (including via telehealth), and exempts the stockpile operations from certain restrictions, all of which expand access to medication abortion, provider capabilities, and public funding for these drugs.

Related bills

Sponsors

Text versions

History (2 actions)
DateChamberAction
2026-01-07Areferred to health
2025-11-21Areferred to health